New Ag Tool: Plant Hormone that Speeds Root Growth

Scientists have identified a plant hormone, beta-cyclocitral, that makes tomato and rice plant roots grow faster and branch more. The hormone could help farmers enhance crop plant growth.

Biologist Examining Plant Roots

A molecule sold as a food additive has an underground role, too: helping roots grow faster.

When added to soil, the molecule, called beta-cyclocitral, speeds root growth in rice and tomato plants, scientists report May 8, 2019, in the journal Proceedings of the National Academy of Sciences. It also makes rice plants resistant to salty soil, which usually turns plants sickly and stunted. The molecule, a hormone found naturally in plants, could be a useful tool for farmers seeking healthier and more drought-resistant crops.

For centuries, plants have been bred for vigorous foliage and other easily visible traits. Because roots are hidden underground, “they’ve been largely ignored,” says developmental biologist Philip Benfey, a Howard Hughes Medical Institute investigator at Duke University.

And yet, roots make up half the plant, points out coauthor Jazz Dickinson, also at Duke. She and Benfey wanted to find plant hormones that affected root development. Their previous research had hinted that some molecule chemically related to carotenoids – the pigments that give carrots their vibrant orange hue – might be important. But the researchers weren’t sure exactly which one, Dickinson says.

Many of these carotenoid relatives have been repurposed and are available commercially as food additives or dietary supplements. Dickinson rounded up about 20 and tested their effects on a common lab plant, Arabidopsis. She added each compound to the clear agar gel in which the plants were growing – a setup that let her easily see the roots – and monitored what happened over 10 days.

“Beta-cyclocitral stood out,” she says. It made the roots grow faster and also branch out more. And it had the same effect in rice and tomato plants, follow-up tests showed.

In rice plants, the team noticed an even more striking effect: the plants could also withstand salty soil. Irrigation of farm fields can make soil saltier, especially near the top. The team mimicked those conditions in the lab, and then watched how rice plants grew. “Untreated rice plants were very unhappy with that level of salt,” Benfey says. But with beta-cyclocitral added, the plants didn’t seem perturbed.

It’s possible that the compound helped the roots push down through the salty topsoil to reach the deeper, less-salty soil more quickly, Dickinson proposes.

The researchers hope that beta-cyclocitral will be useful agriculturally, either added to soil or sprayed onto crops. And since the molecule worked in both rice and tomatoes – two very different plants – it may boost root growth in crops more broadly.

[Originally posted by HHMI, May 9, 2019]

READ THE FULL STORY HERE

HARVEY Helps Move Bioprinted Organs Closer to Reality

Supercomputer code successfully models behavior of interwoven vasculature created with new 3D printing technique

Supercomputer code successfully models behavior of interwoven vasculature created with new 3D printing technique

With the help of a dash of turmeric and blueberry, bioengineers have developed a technique for 3D printing complex, interwoven vascular networks that mimic many of the movements and forces of those found in real organs.

The technique could help researchers understand how the flexing of entangled pathways for blood, air, lymph and other vital fluids affect each systems’ function and move the field closer toward bioprinting entire organs.

To better understand the forces and stresses at work in the new networks, the researchers turned to one of the world’s most sophisticated systems for computationally modelling blood flow. Developed by Amanda Randles, the Alfred Winborne and Victoria Stover Mordecai Assistant Professor of Biomedical Sciences at Duke University, HARVEY is a supercomputer code capable of simulating blood flow through the human vasculature down to the cellular level.

Led by bioengineers Jordan Miller of Rice University and Kelly Stevens of the University of Washington (UW), the research appears online on the cover of Science on May 3. It includes a visually stunning proof-of-principle—a hydrogel model of a lung-mimicking air sac in which airways deliver oxygen to surrounding blood vessels.

“One of the biggest road blocks to generating functional tissue has been our inability to print the complex vasculature that can supply nutrients to densely populated tissues,” said Miller, assistant professor of bioengineering at Rice’s Brown School of Engineering. “Our organs contain independent vascular networks—like the airways and blood vessels of the lung or the bile ducts and blood vessels in the liver. These interpenetrating networks are physically and biochemically entangled, and the architecture itself is intimately related to tissue function. Ours is the first bioprinting technology that addresses the challenge of multivascularization in a direct and comprehensive way.”

The new open-source bioprinting technology is dubbed the “stereolithography apparatus for tissue engineering,” or SLATE. The system works by printing a sequence of layers from a liquid pre-hydrogel solution that becomes a solid when exposed to blue light.

 

Read the full story here

[Originally posted by Duke Pratt School of Engineering — May 2, 2019]

inSoma Bio, Inc.

DUKE INVENTOR: Stefan Roberts, Tosh Chilkoti

insomabio.com

INSPIRED BY NATURE, MOTIVATED BY HEALTH

Creating unique biomaterials to solve problems in tissue engineering and regenerative medicine by borrowing nature’s own designs, integrating biology and materials science.

PROTEINS AS INJECTABLE MATERIALS

Proteins form the essential, insoluble backbone of our cellular environment. We genetically engineer protein-based materials to mimic those naturally found in this environment. By borrowing from nature’s toolbox, we further modify these proteins to assemble only with body heat allowing complex cellular environments to be created with simple solution injections.

Tumult Labs

DUKE INVENTOR: Ashwin Machanavajjhala
tmlt.io

Tumult Labs builds state-of-the-art privacy technology to enable the effective use of data while respecting the privacy of contributing individuals. Their technology enables the safe release of de-identified data, statistics, and machine learning models. All of their solutions satisfy differential privacy, an ironclad, mathematically-proven privacy guarantee.

Xilis

DUKE INVENTOR: Xiling Shen, David Hsu
xilis.net

Cancer is the second leading cause of death in the U.S and metastatic disease remains predominantly incurable. New cancer cases and healthcare costs continue to increase year-over-year. Precision medicine aims to select the most effective treatments for patients, but existing approaches only benefit a minority of patients.

 

Xilis is developing next generation micro-organosphere technology for precision cancer therapy. The XilisμO platform enables rapid diagnostics, personalized drug screening, and scalable patient-derived models for high-throughput drug discovery.

 

Avalo Biosciences

DUKE INVENTOR: Mariano Alvarez, Brendan Collins

avalo.ai

Avalo has developed a proprietary algorithm to predict complex traits either for polygenic human diseases or for AgTech.

They believe that their algorithm is superior certainly superior to linear regression machine learning but also to more sophisticated competitors.

For AgTech – the technology can assist with crop quality, disease resistance, etc. For human disease, the technology could be used to predict multiple genes contributing to a polygenic disease in each patient.

SafineAI's new type of microscope that uses a bowl studded with LED lights of various colors and lighting schemes produced by machine learning.

SafineAI

DUKE INVENTOR: Roark Horstmeyer
safineai.com

Basic blood tests require significant manual effort and are ubiquitous bottlenecks in healthcare systems. SafineAI seeks to develop a new “intelligent” computational microscope that, combined with cloud-based machine learning algorithms, will automate blood analysis and open up new diagnostic possibilities.

Duke engineering graduate students formed SafineAI to miniaturize a reconfigurable LED microscope. This concept has already earned them a $120,000 prize at a local pitch competition.

This microscope adapts its lighting angles, colors, and patterns while teaching itself the optimal settings needed to complete a given diagnostic task. In the initial proof-of-concept study, the microscope simultaneously developed a lighting pattern and classification system that allowed it to quickly identify red blood cells infected by the malaria parasite more accurately than trained physicians and other machine learning approaches.

The research was published in Biomedical Optics Express, a publication of The Optical Society (OSA) (www.dx.doi.org/10.1364/BOE.10.006351).

Simbuka

DUKE INVENTOR: Edgard Ngaboyamahina

simbuka.africa

Simbuka is a Social Enterprise registered in Rwanda that positions environmental technologies and solutions for private sector investment and scale through technology validation and identification of an appropriate business model. Simbuka develops and implements adequate pilot programs to ensure the required resources are available and demonstrate economic viability in Rwanda and across the continent. By leveraging existing non-government and government programs in environmental management, WaSH (Water, Sanitation, and Hygiene) and manufacturing, Simbuka identifies appropriate partners to integrate innovation into the wider socio-economic framework, thus safeguarding continuation beyond the initial deployment.

Simbuka is currently exploring pilot opportunities and business models for technologies developed by the Duke University Center for Water, Sanitation, Hygiene and Infectious Disease (WaSH-AID)North Carolina State University, and Triangle Environmental.

simbuka technological innovations logo
S.H.E. is a fully automated, sterile, sanitary pad disposal unit engineered to provide dignity and privacy, waste reduction and safe hygiene.
S.H.E. is a fully automated, sterile, sanitary pad disposal unit engineered to provide dignity and privacy, waste reduction and safe hygiene.

S.H.E. – Safe Hygiene for Everyone

Menstrual Hygiene and Health (MHH) is a neglected sanitation topic in emerging markets, and menstrual waste disposal is particularly absent in many shared and public settings. Waste streams are growing with increased urbanization and access to disposable products. Safe, discreet and compact disposal options, such as the S.H.E., can empower women and girls, support better health and a cleaner environment. S.H.E. is a fully automated, sterile, sanitary pad disposal unit engineered to provide dignity and privacy, waste reduction and safe hygiene. With a capacity of up to 15 pads at a time and a processing time under 15 minutes, S.H.E. thermally treats pads between 800 and 900°C, emitting virtually no smoke and producing minimal ash.  Center for WaSH-AIDBiomass Controls

Dr. Ngaboyamahina

NgaboyamahinaDr. Ngaboyamahina is the Founder and Managing Director of Simbuka. He’s also a Research Scientist at the Duke Center for WaSH-AID (Water, Sanitation, Hygiene and Infectious Disease) where he leads R&D activities that encompass waste treatment and technology transfer under the Bill & Melinda Gates Foundation-supported Reinvent the Toilet Challenge. The Center for WaSH-AID is an intensely collaborative translational research team, working closely with academic, non-profit, and private industry partners to facilitate the development and sustainable deployment of novel technology-based health solutions around the world.

Immcure

DUKE INVENTOR: Qi-Jing Li, Xiao-Fan Wang
immcure.com

Immcure aims to develop next-generation cancer immunotherapies that control tumor progression, convert cancers to manageable chronic diseases, and eventually lead to a cure.

immcure logo

Memory / Exhaustion resistant CAR-T / TCR-T therapy

Immcure’s unique T cell genetic engineering platform is geared to modify T cells for enhanced therapeutic potential, which includes memory T cell differentiation programs and exhaustion resistant T cell transformation programs. CAR-T and TCR-T products armed with such modifications can achieve prolonged cancer metastasis control as well as improved efficacy reach the purpose of preventing metastasis as well as improving the efficacy.